Relación entre los niveles de troponinas cardíacas en pacientes con síndrome coronario agudo con elevación del ST en el desarrollo de insuficiencia cardíaca en el Hospital Teodoro Maldonado Carbo en el año 2018.

Abstract

INTRODUCTION: Cardiac biomarkers have innovated the scenario of acute myocardial infarction, in determining cardiovascular risk and the subsequent period, where possible complications are evaluated; among the most frequent is heart failure. OBJECTIVES: To determine the association between troponin elevation in ST elevation coronary syndrome with the development of heart failure. METHODOLOGY: Observational, descriptive, retrospective, and cross-sectional study in patients with a history of coronary syndrome with ST elevation performed at the Teodoro Maldonado Carbo Hospital during the period 2018. There was a population of 838 patients and, applying inclusion and exclusion criteria 128 were studied. RESULTS: Of 128 patients, 65 patients developed heart failure after the episode of STEACS. Furthermore, most of the patients with STEACS, that is, 58.46% of the sample presented reduced EF. From the total sample, it is shown that the mean survival after STEACS is 48.27 months (CI: 41.22-55.32). Regarding the troponin values at admission, the area under the curve was 0.509 (p = 0.866); during the area under the curve, it was 0.544 (p = 0.394) and at discharge the area under the curve was 0.509 (p = 0866) giving as results p> 0.005, that is, not significant. CONCLUSIONS: There is no association between troponin levels and the development of heart failure, older adults and men have a higher percentage of heart failure, heart failure with reduced LVEF occurs more than preserved LVEF, survival of patients with STEACS is low and decreases even more when LVEF is reduced.